Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals (Q40632660)

22 September 2017

Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals (English)

1 reference

22 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Holger Jon Møller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Søren Kragh Moestrup

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jesper Eugen-Olsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Thomas Benfield

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Gideon Ertner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Gitte Kronborg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Troels Bygum Knudsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

28 June 2016

1 reference

Journal of Infectious Diseases

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1198-1204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Microbial translocation, immune activation, and HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Immune activation and inflammation in HIV-1 infection: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Plasma levels of soluble CD14 independently predict mortality in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Identification of the haemoglobin scavenger receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Cohort profile: the Danish HIV cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

The Danish Register of Causes of Death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

The Danish National Patient Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Soluble CD163 is associated with shortened telomere length in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW263

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIW263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27354366%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference